End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
152 SAR | -4.28% | +3.12% | +16.74% |
04-24 | Tadawul Shares in Red as Saudi Arabia's Merchandise Export Falls | MT |
04-21 | Saudi Stocks Welcome New Trading Week in the Green | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 53% by 2026.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The firm trades with high earnings multiples: 26.67 times its 2024 earnings per share.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.74% | 6.08B | C | ||
+13.21% | 9.63B | B- | ||
+91.91% | 4.16B | - | ||
-1.08% | 2.31B | B+ | ||
-20.94% | 1.01B | C | ||
+2.18% | 862M | - | D+ | |
+85.42% | 748M | - | C | |
+7.80% | 162M | - | - | |
-8.15% | 68.79M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 8010 Stock
- Ratings The Company for Cooperative Insurance